Frontiers | Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis
Plasma Chromogranin A Levels Predict Survival and Tumor Response in Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors | Anticancer Research
An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan | Scientific Reports
Cancers | Free Full-Text | Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67 | Annals of Surgical Oncology
![PDF] Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dbefbcff3d1adac4d9382c85f93ecfd16024f5f9/3-Figure1-1.png "PDF] Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. | Semantic Scholar")
PDF] Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. | Semantic Scholar
C-reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms | Scientific Reports
Pathophysiology and Treatment of Pancreatic Neuroendocrine Neoplasms (PNENS): New Developments - Endotext - NCBI Bookshelf
Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014 | BMC Endocrine Disorders | Full Text
Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study - ScienceDirect
Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study - The Lancet Regional Health – Europe
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors | NEJM
Pancreatic neuroendocrine tumor - Wikipedia
Prognostic factors of long‑term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12‑year experience from a single center
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study | Journal of Clinical Oncology
Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations
Kaplan–Meier analyses of overall survival. (a) Overall survival in... | Download Scientific Diagram
Prognosis of Patients with Neuroendocrine Neoplasms of the Pancre
Survivals of pancreatic neuroendocrine tumors with different grade by... | Download Scientific Diagram
Kaplan–Meier survival curves of 926 neoplasms by the European... | Download Scientific Diagram
Time-trend and recurrence analysis of pancreatic neuroendocrine tumors in: Endocrine Connections Volume 8 Issue 7 (2019)
Death incidence and survival by European Neuroendocrine Tumor Society... | Download Scientific Diagram
Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors - Min Shi, Biao Zhou, 2021
Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines in: Endocrine-Related Cancer Volume 24 Issue 2 (2017)
